1
|
Yong TL, Zaman R, Rehman N, Tan CK. Ceramides and Skin Health: New Insights. Exp Dermatol 2025; 34:e70042. [PMID: 39912256 DOI: 10.1111/exd.70042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2024] [Revised: 01/11/2025] [Accepted: 01/22/2025] [Indexed: 02/07/2025]
Abstract
Ceramide has transitioned from an incidental discovery to a vital element in skincare, becoming a thoroughly studied compound in the quest to treat skin conditions. Creating a moisture barrier, preserving hydration, regulating pH, controlling inflammation, and enhancing skin functions and appearance are among its established benefits. It is often used medically to repair skin barrier defects, as observed in inflammatory skin conditions like atopic dermatitis (AD) and dry skin types. Furthermore, ceramide and its metabolites are commonly used as predictors before disease manifestation and for prognostication processes, thus can be used as biomarker for clinical diagnosis as well. In the last couple of decades, momentum was also seen in the pre-clinical studies involving anti-cancer and nanotechnology field, whereby ceramide was also used as a drug, a carrier, or even adjunct formulation to increase efficacy of treatment such as chemotherapy. Approaches to increase ceramide levels include directly replenishing lost ceramides with natural extracts, synthetic pseudo-ceramides, or ceramide-like analogues, as well as using supplements that stimulate the body's natural ceramide production. Although ceramide is a well-known treatment in skincare and for common skin conditions like AD and psoriasis, its development and related pharmacology for severe skin conditions, such as skin cancer, remain in pre-clinical stages. Hence, the purpose of this research is to explore the role of ceramide in skin health and its application in common skin diseases.
Collapse
Affiliation(s)
- Tze Lek Yong
- School of Healthy Aging, Aesthetic and Regenerative Medicine, Faculty of Medicine and Health Sciences, UCSI University, Kuala Lumpur, Malaysia
| | - Rahela Zaman
- School of Healthy Aging, Aesthetic and Regenerative Medicine, Faculty of Medicine and Health Sciences, UCSI University, Kuala Lumpur, Malaysia
| | | | - Chung Keat Tan
- School of Healthy Aging, Aesthetic and Regenerative Medicine, Faculty of Medicine and Health Sciences, UCSI University, Kuala Lumpur, Malaysia
| |
Collapse
|
2
|
Yang MY, Lee E, Park CS, Nam YS. Molecular Dynamics Investigation into CerENP's Effect on the Lipid Matrix of Stratum Corneum. J Phys Chem B 2024; 128:5378-5386. [PMID: 38805566 DOI: 10.1021/acs.jpcb.4c00053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2024]
Abstract
The extracellular lipid matrix in the stratum corneum (SC) plays a critical role in skin barrier functionality, comprising three primary components: ceramides, cholesterol, and free fatty acids. The diverse ceramides, differentiated by molecular structures such as hydroxylations and varying chain lengths, are essential for the lipid matrix's structural integrity. Recently, a new subclass of ceramide, 1-O-acylceramide NP (CerENP), has been identified; however, its precise role in the lipid matrix of the SC is still elusive. Herein, we investigate the role of CerENP on the structure and permeability of the SC using molecular dynamics simulations. Our findings indicate that CerENP contributes to a compact lipid matrix in the lateral dimension of our SC model with a repeat distance of about 13 nm. Additionally, ethanol permeability assessments show that CerENP effectively reduces molecular penetration through the lipid matrix. This study provides an insight into the role of a new subclass of ceramide in the SC, enhancing our understanding of skin structure and the mechanisms behind barrier dysfunction in skin diseases.
Collapse
Affiliation(s)
- Moon Young Yang
- Materials and Process Simulation Center, California Institute of Technology, Pasadena, California 91125, United States
| | - Eunok Lee
- LCS Biotech Co. Ltd., 11-2, Deokseongsandan 2-ro 50, Idong-eup, Cheoin-gu, Yongin-si 17130, Gyeonggi-do, Republic of Korea
| | - Chang Seo Park
- LCS Biotech Co. Ltd., 11-2, Deokseongsandan 2-ro 50, Idong-eup, Cheoin-gu, Yongin-si 17130, Gyeonggi-do, Republic of Korea
| | - Yoon Sung Nam
- Department of Materials Science and Engineering, Korea Advanced Institute of Science and Technology, 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea
- Department of Biological Sciences, Korea Advanced Institute of Science and Technology, 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea
| |
Collapse
|
3
|
Rabionet M, Bernard P, Pichery M, Marsching C, Bayerle A, Dworski S, Kamani MA, Chitraju C, Gluchowski NL, Gabriel KR, Asadi A, Ebel P, Hoekstra M, Dumas S, Ntambi JM, Jacobsson A, Willecke K, Medin JA, Jonca N, Sandhoff R. Epidermal 1-O-acylceramides appear with the establishment of the water permeability barrier in mice and are produced by maturating keratinocytes. Lipids 2022; 57:183-195. [PMID: 35318678 DOI: 10.1002/lipd.12342] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2022] [Revised: 03/11/2022] [Accepted: 03/11/2022] [Indexed: 12/17/2022]
Abstract
1-O-Acylceramides (1-OACs) have a fatty acid esterified to the 1-hydroxyl of the sphingosine head group of the ceramide, and recently we identified these lipids as natural components of human and mouse epidermis. Here we show epidermal 1-OACs arise shortly before birth during the establishment of the water permeability barrier in mice. Fractionation of human epidermis indicates 1-OACs concentrate in the stratum corneum. During in vitro maturation into reconstructed human epidermis, human keratinocytes dramatically increase 1-OAC levels indicating they are one source of epidermal 1-OACs. In search of potential enzymes responsible for 1-OAC synthesis in vivo, we analyzed mutant mice with deficiencies of ceramide synthases (Cers2, Cers3, or Cers4), diacylglycerol acyltransferases (Dgat1 or Dgat2), elongase of very long fatty acids 3 (Elovl3), lecithin cholesterol acyltransferase (Lcat), stearoyl-CoA desaturase 1 (Scd1), or acidic ceramidase (Asah1). Overall levels of 1-OACs did not decrease in any mouse model. In Cers3 and Dgat2-deficient epidermis they even increased in correlation with deficient skin barrier function. Dagt2 deficiency reshapes 1-OAC synthesis with an increase in 1-OACs with N-linked non-hydroxylated fatty acids and a 60% decrease compared to control in levels of 1-OACs with N-linked hydroxylated palmitate. As none of the single enzyme deficiencies we examined resulted in a lack of 1-OACs, we conclude that either there is functional redundancy in forming 1-OAC and more than one enzyme is involved, and/or an unknown acyltransferase of the epidermis performs the final step of 1-OAC synthesis, the implications of which are discussed.
Collapse
Affiliation(s)
- Mariona Rabionet
- Lipid Pathobiochemistry Group, German Cancer Research Center, Heidelberg, Germany
| | - Pauline Bernard
- Infinity, Université Toulouse, CNRS, Inserm, UPS, Toulouse, France
| | - Melanie Pichery
- Infinity, Université Toulouse, CNRS, Inserm, UPS, Toulouse, France
| | - Christian Marsching
- Lipid Pathobiochemistry Group, German Cancer Research Center, Heidelberg, Germany.,Center for Applied Research in Biomedical Mass Spectrometry (ABIMAS), Mannheim, Germany.,Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim University of Applied Sciences, Mannheim, Germany.,Instrumental Analytics and Bioanalytics, Mannheim University of Applied Sciences, Mannheim, Germany
| | - Aline Bayerle
- Lipid Pathobiochemistry Group, German Cancer Research Center, Heidelberg, Germany
| | - Shaalee Dworski
- Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada
| | | | - Chandramohan Chitraju
- Department of Genetics and Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.,Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA
| | - Nina L Gluchowski
- Department of Genetics and Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.,Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.,Division of Gastroenterology and Nutrition, Boston Children's Hospital, Boston, Massachusetts, USA
| | - Katlyn R Gabriel
- Department of Genetics and Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.,Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.,Howard Hughes Medical Institute, Boston, Massachusetts, USA
| | - Abolfazl Asadi
- Department of Molecular Biosciences, The Wenner-Gren Institute, The Arrhenius Laboratories, Stockholm University, Stockholm, Sweden
| | - Philipp Ebel
- Molecular Genetics, Life and Medical Sciences Institute (LIMES), University of Bonn, Bonn, Germany
| | - Menno Hoekstra
- Leiden Academic Centre for Drug Research, Division of BioTherapeutics, Leiden University, Leiden, Netherlands
| | - Sabrina Dumas
- Department of Nutritional sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA
| | - James M Ntambi
- Department of Nutritional sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA.,Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA
| | - Anders Jacobsson
- Department of Molecular Biosciences, The Wenner-Gren Institute, The Arrhenius Laboratories, Stockholm University, Stockholm, Sweden
| | - Klaus Willecke
- Molecular Genetics, Life and Medical Sciences Institute (LIMES), University of Bonn, Bonn, Germany
| | - Jeffrey A Medin
- Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada.,University Health Network, Toronto, Ontario, Canada.,Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.,Medical College of Wisconsin, Milwaukee, Wisconsin, USA
| | - Nathalie Jonca
- Infinity, Université Toulouse, CNRS, Inserm, UPS, Toulouse, France.,CHU Toulouse, Hôpital Purpan, Laboratoire de Biologie Cellulaire et Cytologie, Institut Fédératif de Biologie, Toulouse, France
| | - Roger Sandhoff
- Lipid Pathobiochemistry Group, German Cancer Research Center, Heidelberg, Germany.,Center for Applied Research in Biomedical Mass Spectrometry (ABIMAS), Mannheim, Germany
| |
Collapse
|
4
|
Poad BLJ, Marshall DL, Harazim E, Gupta R, Narreddula VR, Young RSE, Duchoslav E, Campbell JL, Broadbent JA, Cvačka J, Mitchell TW, Blanksby SJ. Combining Charge-Switch Derivatization with Ozone-Induced Dissociation for Fatty Acid Analysis. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY 2019; 30:2135-2143. [PMID: 31347025 DOI: 10.1007/s13361-019-02285-5] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/03/2019] [Revised: 07/07/2019] [Accepted: 07/08/2019] [Indexed: 06/10/2023]
Abstract
The specific positions of carbon-carbon double bond(s) within an unsaturated fatty acid exert a significant effect on the physical and chemical properties of the lipid that ultimately inform its biological function(s). Contemporary liquid chromatography-mass spectrometry (MS) strategies based on electrospray ionization coupled to tandem MS can easily detect fatty acyl lipids but generally cannot reveal those specific site(s) of unsaturation. Herein, we describe a novel and versatile workflow whereby fatty acids are first converted to fixed charge N-(4-aminomethylphenyl)pyridinium (AMPP) derivatives and subsequently subjected to ozone-induced dissociation (OzID) on a modified triple quadrupole mass spectrometer. The AMPP modification enhances the detection of fatty acids introduced by direct infusion. Fragmentation of the derivatized fatty acids also provides diagnostic fragment ions upon collision-induced dissociation that can be targeted in precursor ion scans to subsequently trigger OzID analyses in an automated data-dependent workflow. It is these OzID analyses that provide unambiguous assignment of carbon-carbon double bond locations in the AMPP-derivatized fatty acids. The performance of this analysis pipeline is assessed in profiling the patterns of unsaturation in fatty acids within the complex biological secretion vernix caseosa. This analysis uncovers significant isomeric diversity within the fatty acid pool of this sample, including a number of hitherto unreported double bond positional isomers that hint at the activity of potentially new metabolic pathways.
Collapse
Affiliation(s)
- Berwyck L J Poad
- Central Analytical Research Facility, Queensland University of Technology, Brisbane, Australia.
| | - David L Marshall
- Central Analytical Research Facility, Queensland University of Technology, Brisbane, Australia
| | - Eva Harazim
- Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic
| | - Rajesh Gupta
- Central Analytical Research Facility, Queensland University of Technology, Brisbane, Australia
| | - Venkateswara R Narreddula
- School of Chemistry, Physics and Mechanical Engineering, Queensland University of Technology, Brisbane, Australia
| | - Reuben S E Young
- School of Chemistry, Physics and Mechanical Engineering, Queensland University of Technology, Brisbane, Australia
| | | | | | - James A Broadbent
- SCIEX, Concord, ON, Canada
- CSIRO Agriculture and Food, St Lucia, Queensland, 4067, Australia
| | - Josef Cvačka
- Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic
| | - Todd W Mitchell
- School of Medicine and Molecular Horizons, University of Wollongong, Wollongong, Australia
| | - Stephen J Blanksby
- Central Analytical Research Facility, Queensland University of Technology, Brisbane, Australia.
| |
Collapse
|
5
|
Narreddula VR, Boase NR, Ailuri R, Marshall DL, Poad BL, Kelso MJ, Trevitt AJ, Mitchell TW, Blanksby SJ. Introduction of a Fixed-Charge, Photolabile Derivative for Enhanced Structural Elucidation of Fatty Acids. Anal Chem 2019; 91:9901-9909. [DOI: 10.1021/acs.analchem.9b01566] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Affiliation(s)
- Venkateswara R. Narreddula
- School of Chemistry, Physics and Mechanical Engineering, Queensland University of Technology, Brisbane, QLD 4000, Australia
- Central Analytical Research Facility, Institute for Future Environments, Queensland University of Technology, Brisbane, QLD 4000, Australia
| | - Nathan R. Boase
- School of Chemistry, Physics and Mechanical Engineering, Queensland University of Technology, Brisbane, QLD 4000, Australia
| | - Ramesh Ailuri
- School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia
- Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia
| | - David L. Marshall
- Central Analytical Research Facility, Institute for Future Environments, Queensland University of Technology, Brisbane, QLD 4000, Australia
| | - Berwyck L.J. Poad
- Central Analytical Research Facility, Institute for Future Environments, Queensland University of Technology, Brisbane, QLD 4000, Australia
| | - Michael J. Kelso
- School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia
- Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia
| | - Adam J. Trevitt
- School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia
| | - Todd W. Mitchell
- School of Medicine, University of Wollongong, Wollongong, NSW 2522, Australia
- Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia
| | - Stephen J. Blanksby
- School of Chemistry, Physics and Mechanical Engineering, Queensland University of Technology, Brisbane, QLD 4000, Australia
- Central Analytical Research Facility, Institute for Future Environments, Queensland University of Technology, Brisbane, QLD 4000, Australia
| |
Collapse
|